What does DR.MAES - DR.RYCKAERT do?

DR.MAES - DR.RYCKAERT is a specialist medical practice in Sint-Niklaas. Private Limited, started on 27 May 2005, 2 establishments.

What is the address of DR.MAES - DR.RYCKAERT?

The registered office of DR.MAES - DR.RYCKAERT is located at Bosstraat 17, 9111 Sint-Niklaas.

Is DR.MAES - DR.RYCKAERT still active?

Yes. According to the CBE (1 October 2026) DR.MAES - DR.RYCKAERT is active, legal situation “Normale toestand”, started on 27 May 2005.

Is DR.MAES - DR.RYCKAERT registered on Peppol?

Yes, DR.MAES - DR.RYCKAERT is registered on the Peppol network with ID 0208:0874087586.

What is the enterprise number of DR.MAES - DR.RYCKAERT?

The enterprise number of DR.MAES - DR.RYCKAERT is BE0874087586.

When was DR.MAES - DR.RYCKAERT founded?

DR.MAES - DR.RYCKAERT was founded on 27 May 2005.

Who are the directors of DR.MAES - DR.RYCKAERT?

According to the 2025 annual accounts, the directors of DR.MAES - DR.RYCKAERT are: Bart MAES, Ilse RYCKAERT.

Is DR.MAES - DR.RYCKAERT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 May 2005; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR.MAES - DR.RYCKAERT make in 2025?

DR.MAES - DR.RYCKAERT posted a profit after taxes of € 118,522 in financial year 2025.

What is the revenue of DR.MAES - DR.RYCKAERT?

As a small company, DR.MAES - DR.RYCKAERT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 213,118.

DR.MAES - DR.RYCKAERT (Private Limited) - Sint-Niklaas

Dossier DR.MAES - DR.RYCKAERT, printed on 1 October 2026 from databakkes.be/en/0874087586/dr-maes-dr-ryckaert. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 30 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR.MAES - DR.RYCKAERT from Sint-Niklaas, company number BE0874087586, closed financial year 2025 with a result of € 118,522 after tax. For that financial year DR.MAES - DR.RYCKAERT recorded a gross margin of € 213,118 and equity of € 842,520. Compared with financial year 2024, the result moved from € 119,983 to € 118,522. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 8, 2026.

What it is worth Growing

€ 842,520

▲ 5% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 118,522

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 279,664

▲ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 75,000 paid out

63 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 27,278

▼ 29% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 7,508

▲ 88% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 25,450

▲ 94% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 180,439 Gross margin 2022: € 180,439 First fiscal year in the series	€ 228,074 Gross margin 2023: € 228,074 ▲ 26% vs 2022 (€ 180,439) Favourable step	€ 236,183 Gross margin 2024: € 236,183 ▲ 4% vs 2023 (€ 228,074) Favourable step	€ 213,118 Gross margin 2025: € 213,118 ▼ 10% vs 2024 (€ 236,183) Unfavourable step	▼ 10%
Profit after taxes	€ 99,529 Profit after taxes 2022: € 99,529 First fiscal year in the series	€ 129,735 Profit after taxes 2023: € 129,735 ▲ 30% vs 2022 (€ 99,529) Favourable step	€ 119,983 Profit after taxes 2024: € 119,983 ▼ 8% vs 2023 (€ 129,735) Unfavourable step	€ 118,522 Profit after taxes 2025: € 118,522 ▼ 1% vs 2024 (€ 119,983) Unfavourable step	▼ 1%
Equity	€ 575,280 Equity 2022: € 575,280 First fiscal year in the series	€ 705,015 Equity 2023: € 705,015 ▲ 23% vs 2022 (€ 575,280) Favourable step	€ 798,999 Equity 2024: € 798,999 ▲ 13% vs 2023 (€ 705,015) Favourable step	€ 842,520 Equity 2025: € 842,520 ▲ 5% vs 2024 (€ 798,999) Favourable step	▲ 5%
Total debts	€ 1,135,668 Total debts 2022: € 1,135,668 First fiscal year in the series	€ 1,118,234 Total debts 2023: € 1,118,234 ▼ 2% vs 2022 (€ 1,135,668) Favourable step	€ 1,137,100 Total debts 2024: € 1,137,100 ▲ 2% vs 2023 (€ 1,118,234) Unfavourable step	€ 1,228,213 Total debts 2025: € 1,228,213 ▲ 8% vs 2024 (€ 1,137,100) Unfavourable step	▲ 8%
Cash	€ 236,580 Cash 2022: € 236,580 First fiscal year in the series	€ 215,194 Cash 2023: € 215,194 ▼ 9% vs 2022 (€ 236,580) Unfavourable step	€ 265,508 Cash 2024: € 265,508 ▲ 23% vs 2023 (€ 215,194) Favourable step	€ 279,664 Cash 2025: € 279,664 ▲ 5% vs 2024 (€ 265,508) Favourable step	▲ 5%
Land & buildings	€ 638,920 Land & buildings 2022: € 638,920 First fiscal year in the series	€ 612,058 Land & buildings 2023: € 612,058 ▼ 4% vs 2022 (€ 638,920) Unchanged	€ 585,622 Land & buildings 2024: € 585,622 ▼ 4% vs 2023 (€ 612,058) Unchanged	€ 559,469 Land & buildings 2025: € 559,469 ▼ 4% vs 2024 (€ 585,622) Unchanged	▼ 4%
Retained profit	€ 525,280 Retained profit 2022: € 525,280 First fiscal year in the series	€ 655,015 Retained profit 2023: € 655,015 ▲ 25% vs 2022 (€ 525,280) Favourable step	€ 748,999 Retained profit 2024: € 748,999 ▲ 14% vs 2023 (€ 655,015) Favourable step	€ 792,520 Retained profit 2025: € 792,520 ▲ 6% vs 2024 (€ 748,999) Favourable step	▲ 6%
Dividend	€ 131,713 Dividend 2022: € 131,713 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 131,713) Unchanged	€ 26,000 Dividend 2024: € 26,000 Unchanged (€ 0) Unchanged	€ 75,000 Dividend 2025: € 75,000 ▲ 188% vs 2024 (€ 26,000) Unchanged	▲ 188%
Bank debt	€ 1,014 Bank debt 2022: € 1,014 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 1,014) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,710,948 Balance sheet total 2022: € 1,710,948 First fiscal year in the series	€ 1,823,250 Balance sheet total 2023: € 1,823,250 ▲ 7% vs 2022 (€ 1,710,948) Unchanged	€ 1,936,098 Balance sheet total 2024: € 1,936,098 ▲ 6% vs 2023 (€ 1,823,250) Unchanged	€ 2,070,733 Balance sheet total 2025: € 2,070,733 ▲ 7% vs 2024 (€ 1,936,098) Unchanged	▲ 7%

Key figures of DR.MAES - DR.RYCKAERT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to DR.MAES - DR.RYCKAERT?

What happened at DR.MAES - DR.RYCKAERT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 8, 2026 New annual accounts for financial year 2025: profit of € 118,522 (▼ 1% vs 2024). Source: NBB ↗
Apr 1, 2009 New establishment in Sint-Niklaas. KBO
May 27, 2005 New establishment in Sint-Niklaas. KBO
May 27, 2005 Start of the company according to the CBE. KBO

In short

From € 99,529 profit in 2022 to € 118,522 profit in 2025.

Paid € 201,047 in corporate taxes since 2022.

Best year ever: 2023, with € 129,735 profit.

Paid out € 232,713 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR.MAES - DR.RYCKAERT? We notify you, reason included.

Follow DR.MAES - DR.RYCKAERT

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Bart MAES Ilse RYCKAERT

DR.MAES - DR.RYCKAERT

Behind DR.MAES - DR.RYCKAERT are Bart MAES and Ilse RYCKAERT.

See the full network in the app

Directors

According to the 2025 annual accounts

Bart MAES

Director

Ilse RYCKAERT

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Bosstraat 17

9111 Sint-Niklaas

2.299.032.929

Moerlandstraat 1

9100 Sint-Niklaas

Active since 27 May 2005

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0874.087.586
VAT number: BE 0874.087.586
Registered office: Bosstraat 17, 9111 Sint-Niklaas
Names & denominations: DR.MAES - DR.RYCKAERT
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 May 2005
Peppol: Active · Active since 27 Mar 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗